Clozapine associated pulmonary embolism: systematic review
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Community Hospital Internal Medicine Perspectives"
DOI: 10.1080/20009666.2019.1627848
Abstract: ABSTRACT Background: Clozapine is a second-generation antipsychotic used in refractory schizophrenia. Clozapine can lead to pulmonary embolism (PE) by various mechanisms including immobility, weight gain and increased platelet aggregation. Objectives: We performed a systematic review… read more here.
Keywords: clozapine associated; systematic review; pulmonary embolism; clozapine ... See more keywords
Clozapine-Associated Stuttering: A Case Report.
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000001016
Abstract: 1. Black M, Barsoum IB, Truesdell P, et al. Activation of the PD-1/PDL-1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis. Oncotarget. 2016;7:10557–10567. 2. Iwai Y, Hamanishi J, Chamoto K, et al. Cancer… read more here.
Keywords: pembrolizumab; clozapine associated; associated stuttering; cancer ... See more keywords
Successful rechallenge after clozapine-associated myocarditis
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-248909
Abstract: Clozapine is a highly effective medication used in management of treatment-resistant schizophrenia. Clozapine-associated myocarditis (CAM) is a rare but increasingly recognised complication of clozapine titration. Following an episode of CAM, clinicians can face a challenging… read more here.
Keywords: clozapine associated; rechallenge clozapine; clozapine; associated myocarditis ... See more keywords